Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001447028-24-000078)

Filing Details

Accession Number:: 0001447028-24-000078
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2024-08-16 16:07:41
Reporting Period:: 2024-08-14

Accepted Time:: 2024-08-16 16:07:41
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1447028	Arbutus Biopharma Corp	ABUS	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1244828	S Keith Manchester	C/O Arbutus Biopharma Corporation 701 Veterans Circle Warminster PA 18974		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Shares	Acquisiton	2024-08-14	54,915	$0.56	54,915	No	4	M	Direct
Common Shares	Disposition	2024-08-14	8,846	$3.69	46,069	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Shares	Stock Option (Right to Buy)	Disposition	2024-08-14	54,915	$0.00	54,915	$0.56

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2024-11-13	No	4	M	Direct

Footnotes

Cashless exercise and hold transaction in director stock options due to expire on November 13, 2024, ten years after such options were granted, including the sale of 8,846 of the underlying shares to pay the exercise price. None of the net 46,069 shares were sold.
This is a director stock option grant that is fully vested.